Literature DB >> 20945300

Analysis of the aryl hydrocarbon receptor (AhR) signal transduction pathway.

Michael S Denison1, Jane M Rogers, S Renee Rushing, Carol L Jones, Selwyna C Tetangco, Sharon Heath-Pagliuso.   

Abstract

Analysis of the Ah Receptor Signal Transduction Pathway (Michael S. Denison, Jane M. Rohers, S. Renee Rushing. Carol L. Jones, Selwyna C. Tetangico, and Sharon Heath-Pagliuso, University of California, Davis, California).The protocols in this unit will allow researchers to detect the Ah receptor and characterize its functional activities (i.e., ligand binding, transformation and DNA binding, and gene expression) in their biological test system and to use these methods to detect chemical and biochemical events that affect this signaling system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 20945300     DOI: 10.1002/0471140856.tx0408s11

Source DB:  PubMed          Journal:  Curr Protoc Toxicol        ISSN: 1934-9254


  14 in total

1.  Vemurafenib acts as an aryl hydrocarbon receptor antagonist: Implications for inflammatory cutaneous adverse events.

Authors:  Heike C Hawerkamp; Andreas Kislat; Peter A Gerber; Marius Pollet; Katharina M Rolfes; Anatoly A Soshilov; Michael S Denison; Afaque A Momin; Stefan T Arold; Angeliki Datsi; Stephan A Braun; Péter Oláh; Mario E Lacouture; Jean Krutmann; Thomas Haarmann-Stemmann; Bernhard Homey; Stephan Meller
Journal:  Allergy       Date:  2019-09-03       Impact factor: 13.146

2.  Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor.

Authors:  Benjamin J Moyer; Itzel Y Rojas; Iain A Murray; Seokwon Lee; Haley F Hazlett; Gary H Perdew; Craig R Tomlinson
Journal:  Toxicol Appl Pharmacol       Date:  2017-03-20       Impact factor: 4.219

3.  Toxicogenomic evaluation of long-term hepatic effects of TCDD in immature, ovariectomized C57BL/6 mice.

Authors:  Anna K Kopec; Darrell R Boverhof; Rance Nault; Jack R Harkema; Colleen Tashiro; Dave Potter; Bonnie Sharratt; Brock Chittim; Timothy R Zacharewski
Journal:  Toxicol Sci       Date:  2013-07-17       Impact factor: 4.849

4.  SHP-1 is directly activated by the aryl hydrocarbon receptor and regulates BCL-6 in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Authors:  Ashwini S Phadnis-Moghe; Jinpeng Li; Robert B Crawford; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2016-08-18       Impact factor: 4.219

5.  Aryl Hydrocarbon Receptor Activation Suppresses EBF1 and PAX5 and Impairs Human B Lymphopoiesis.

Authors:  Jinpeng Li; Sudin Bhattacharya; Jiajun Zhou; Ashwini S Phadnis-Moghe; Robert B Crawford; Norbert E Kaminski
Journal:  J Immunol       Date:  2017-10-04       Impact factor: 5.422

6.  The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.

Authors:  M Silginer; I Burghardt; D Gramatzki; L Bunse; H Leske; E J Rushing; N Hao; M Platten; M Weller; P Roth
Journal:  Oncogene       Date:  2015-10-26       Impact factor: 9.867

7.  The aryl hydrocarbon receptor mediates leflunomide-induced growth inhibition of melanoma cells.

Authors:  Edmond F O'Donnell; Prasad Rao Kopparapu; Daniel C Koch; Hyo Sang Jang; Jessica Lynne Phillips; Robert L Tanguay; Nancy I Kerkvliet; Siva Kumar Kolluri
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

Review 8.  Changing the face of kynurenines and neurotoxicity: therapeutic considerations.

Authors:  Zsuzsanna Bohár; József Toldi; Ferenc Fülöp; László Vécsei
Journal:  Int J Mol Sci       Date:  2015-04-29       Impact factor: 5.923

9.  The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells.

Authors:  E F O'Donnell; D C Koch; W H Bisson; H S Jang; S K Kolluri
Journal:  Cell Death Dis       Date:  2014-01-30       Impact factor: 8.469

10.  Enantiospecific effects of ketoconazole on aryl hydrocarbon receptor.

Authors:  Aneta Novotna; Martina Korhonova; Iveta Bartonkova; Anatoly A Soshilov; Michael S Denison; Katerina Bogdanova; Milan Kolar; Petr Bednar; Zdenek Dvorak
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.